Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology

Published

Journal Article

© National Comprehensive Cancer Network, Inc. 2015, All rights reserved.Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

Duke Authors

Cited Authors

  • Carroll, PR; Parsons, JK; Andriole, G; Bahnson, RR; Barocas, DA; Castle, EP; Catalona, WJ; Dahl, DM; Davis, JW; Epstein, JI; Etzioni, RB; Farrington, T; Hemstreet, GP; Kawachi, MH; Lange, PH; Loughlin, KR; Lowrance, W; Maroni, P; Mohler, J; Morgan, TM; Nadler, RB; Poch, M; Scales, C; Shaneyfelt, TM; Smaldone, MC; Sonn, G; Sprenke, P; Vickers, AJ; Wake, R; Shead, DA; Freedman-Cass, D

Published Date

  • January 1, 2016

Published In

Volume / Issue

  • 13 / 12

Start / End Page

  • 1534 - 1561

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Citation Source

  • Scopus